Picture of Mesoblast logo

MSB Mesoblast Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual cashflow statement for Mesoblast, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

C2020
June 30th
C2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital27.36.21109.3912.4
Other Operating Cash Flow
Cash from Operating Activities-50.4-101-65.8-63.3-48.5
Capital Expenditures-2.1-1.65-0.157-0.264-0.271
Purchase of Fixed Assets
Other Investing Cash Flow Items-1.180-0.0750.070.174
Sale/Maturity of Investment
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-3.27-1.65-0.232-0.194-0.097
Financing Cash Flow Items-12.2-7.77-11.8-11.5-11.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities131109-9.8774.540.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash78.97.55-76.410.9-8.36